Spotlight on CYP4B1

被引:5
|
作者
Roeder, Annika [1 ]
Huesken, Saskia [2 ]
Hutter, Michael C. [3 ]
Rettie, Allan E. [4 ]
Hanenberg, Helmut [2 ,5 ]
Wiek, Constanze [2 ]
Girhard, Marco [1 ]
机构
[1] Heinrich Heine Univ, Inst Biochem, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany
[3] Saarland Univ, Ctr Bioinformat, D-66123 Saarbrucken, Germany
[4] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98105 USA
[5] Univ Duisburg Essen, Univ Childrens Hosp Essen, Dept Pediatr 3, D-45147 Essen, Germany
关键词
cytochrome P450; structure; bioactivation; xenobiotics; drug metabolism; endobiotic metabolism; cancer; suicide gene; DAMAGED SWEET-POTATOES; COVALENT HEME-BINDING; METABOLIC-ACTIVATION; CYTOCHROME-P450; 4B1; 20-HYDROXYEICOSATETRAENOIC ACID; PERILLA KETONE; SUICIDE GENE; LUNG-CANCER; MUTAGENIC ACTIVATION; BLADDER CARCINOGENS;
D O I
10.3390/ijms24032038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian cytochrome P450 monooxygenase CYP4B1 can bioactivate a wide range of xenobiotics, such as its defining/hallmark substrate 4-ipomeanol leading to tissue-specific toxicities. Similar to other members of the CYP4 family, CYP4B1 has the ability to hydroxylate fatty acids and fatty alcohols. Structural insights into the enigmatic role of CYP4B1 with functions in both, xenobiotic and endobiotic metabolism, as well as its unusual heme-binding characteristics are now possible by the recently solved crystal structures of native rabbit CYP4B1 and the p.E310A variant. Importantly, CYP4B1 does not play a major role in hepatic P450-catalyzed phase I drug metabolism due to its predominant extra-hepatic expression, mainly in the lung. In addition, no catalytic activity of human CYP4B1 has been observed owing to a unique substitution of an evolutionary strongly conserved proline 427 to serine. Nevertheless, association of CYP4B1 expression patterns with various cancers and potential roles in cancer development have been reported for the human enzyme. This review will summarize the current status of CYP4B1 research with a spotlight on its roles in the metabolism of endogenous and exogenous compounds, structural properties, and cancer association, as well as its potential application in suicide gene approaches for targeted cancer therapy.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1
    Mikstacka, Renata
    Rimando, Agnes M.
    Dutkiewicz, Zbigniew
    Stefanski, Tomasz
    Sobiak, Stanislaw
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (17) : 5117 - 5126
  • [42] CYP1B1: A Promising Target in Cancer Drug Discovery
    Fabris, Marcieli
    Silva, Mariana Luiza
    de Santiago-Silva, Kaio Maciel
    Bispo, Marcelle de Lima Ferreira
    Camargo, Priscila Goes
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (09) : 981 - 988
  • [43] Age-related changes in the mRNA levels of CYP1A1, CYP2B1/2 and CYP3A1 isoforms in rat small intestine
    Artur Pałasz
    Anna Wiaderkiewicz
    Ryszard Wiaderkiewicz
    Piotr Czekaj
    Beata Czajkowska
    Tomasz Lebda-Wyborny
    Aneta Piwowarczyk
    Aleksandra Bryzek
    Genes & Nutrition, 2012, 7 : 197 - 207
  • [44] Influence of the Cyp1B1 L432V Gene Polymorphism and Exposure to Tobacco Smoke on Cyp1B1 mRNA Expression in Human Leukocytes
    Helmig, Simone
    Hadzaad, Bahar
    Doehrel, Juliane
    Schneider, Joachim
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (07) : 1490 - 1495
  • [45] Therapeutic Potential of the Inhibition of the Retinoic Acid Hydroxylases CYP26A1 and CYP26B1 by Xenobiotics
    Nelson, Cara H.
    Buttrick, Brian R.
    Isoherranen, Nina
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (12) : 1402 - 1428
  • [46] Expression of microRNAs, CYP1A1 and CYP2B1 in the livers and ovaries of female rats treated with DDT and PAHs
    Chanyshev, M. D.
    Kosorotikov, N. I.
    Titov, S. E.
    Kolesnikov, N. N.
    Gulyaeva, L. F.
    LIFE SCIENCES, 2014, 103 (02) : 95 - 100
  • [47] Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis
    Xu, Wenhuan
    Zhou, Yunhai
    Hang, Xiaosheng
    Shen, Di
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (03) : 2821 - 2829
  • [48] Novel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMR
    Johansson, Tove
    Jurva, Ulrik
    Gronberg, Gunnar
    Weidolf, Lars
    Masimirembwa, Collen
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 571 - 579
  • [49] Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype
    Jorge-Nebert, Lucia F.
    Zhang, Ge
    Wilson, Keith M.
    Jiang, Zhengwen
    Butler, Randall
    Gluckman, Jack L.
    Pinney, Susan M.
    Nebert, Daniel W.
    HUMAN GENOMICS, 2016, 10 : 1 - 17
  • [50] Quercetin acts as an antioxidant and downregulates CYP1A1 and CYP1B1 against DMBA-induced oxidative stress in mice
    Choi, Eun Jeong
    Kim, Taehee
    Kim, Gun-Hee
    ONCOLOGY REPORTS, 2012, 28 (01) : 291 - 296